Mauro Bavetta

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Venues

Dermatologic therapy

Journal of clinical medicine

Expert opinion on biological therapy

Fondazione PTV Policlinico Tor Vergata Dipartimento di Medicina

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione PTV Policlinico Tor Vergata Dipartimento di Medicina Aug 08 2013

Italy

Resident :: Dermatology

Publications

Giacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini, Mauro Bavetta, Clara De Simone, Dario Graceffa, Claudio Bonifati, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Richetta, Ketty Peris, Luca Bianchi
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study. Dermatologic therapy 35 (6) (2022)
Mauro Bavetta, Dionisio Silvaggio, Elena Campione, Pietro Sollena, Vincenzo Formica, Deborah Coletta, Grazia Graziani, Maria Concetta Pucci Romano, Mario Roselli, Ketty Peris, Luca Bianchi
The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions. Journal of clinical medicine 10 (3) (2021)
Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, Mauro Bavetta, Dario Graceffa, Claudio Bonifati, Franca Cantoresi, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Federico Pirro, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Giovanni Richetta, Lidia Sacchelli, Luca Bianchi, Ketty Peris
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy. Expert opinion on biological therapy 21 (9) (2021)
Chiara Pensa, Arianna Piccolo, Arianna Zangrilli, Mauro Bavetta, Luca Bianchi
Risankizumab: How to choose the right dose in clinical practice? Dermatologic therapy 33 (6) (2020)
Arianna Piccolo, Chiara Pensa, Arianna Zangrilli, Mauro Bavetta, Augusto Orlandi, Luca Bianchi
Ixekizumab: One drug for an enigmatic psoriasis. Dermatologic therapy 33 (6) (2020)
Arianna Piccolo, Chiara Pensa, Arianna Zangrilli, Mauro Bavetta, Laura Diluvio, Luca Bianchi
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: Case report. Dermatologic therapy 33 (6) (2020)
Caterina Lanna, Arianna Zangrilli, Mauro Bavetta, Elena Campione, Luca Bianchi
Efficacy and safety of adalimumab in difficult-to-treat psoriasis. Dermatologic therapy 33 (3) (2020)
Laura Diluvio, Mauro Bavetta, Gaetana Costanza, Augusto Orlandi, Luca Bianchi, Elena Campione
Monitoring treatment response in patients affected by actinic keratosis: Dermoscopic assessment and metalloproteinases evaluation after piroxicam 0.8% and sunfilter cream. Dermatologic therapy 32 (1) (2018)
Arianna Zangrilli, Mauro Bavetta, Sara Mazzilli, Virginia Garofalo, Luca Bianchi
Paradoxical case effects of psoriasis following adalimumab therapy: A case series. Dermatologic therapy 31 (6) (2018)

Mauro Bavetta.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mauro Bavetta